2003
Calls on Conference to Seize Historic Opportunity to Improve Quality and Expand Access Through Greater Choice, Competition and Innovation Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a...
World''s Smallest Dual Chamber System Offers Enhanced Therapies to Patients at Risk of Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader...
Worldwide implantable cardioverter defibrillator revenues of $377 million, up 50 percent; Worldwide stent revenue of $224 million, down 2 percent; Favorable product mix generates 75.4 percent...
Next-Generation Stent Design and Excellent Clinical Results Offer Expanded Treatment Options for Patients Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...
European Trial Demonstrates Low Restenosis Rate in Stenting of Small Vessels Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...
Cardiac Resynchronization Therapy-Defibrillator Represents the World''s Most Advanced System Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the...
Corporate Integrity Agreement Strengthens Guidant''s Commitment to Compliance Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has entered into a corporate integrity...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its second quarter 2003 earnings conference...
European Approval Received; New Technology''s Clinical Trial Demonstrated Excellent Results Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Financial Guidance Updated Based on Strong Sales Companywide; Quarterly Dividend to be Paid June 30 INDIANAPOLIS - Guidant Corporation (NYSE: GDT) today announced that the company has made a $10...
No Risk to Patients Implanted with ANCURE ENDOGRAFT System INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced plans to...
X Technologies Receives FX miniRAIL U.S. Food and Drug Administration Approval; Conditions of X Technologies Acquisition Fulfilled; Agreement Expected to Close This Quarter Indianapolis, Ind. -...
Company''s Management to Provide Update on Recent Developments Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
No Risk to Patients Implanted with ANCURE ENDOGRAFT System INDIANAPOLIS - EndoVascular Technologies, Inc. (EVT), a subsidiary of Guidant Corporation, today announced that it has entered into a...
Second Clinical Trial Advances Efforts to Develop Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world...
CMS Decision Leaves Some Seniors Without Coverage for Now Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that an arbitration panel entered a preliminary finding that...
International Symposium Offers Unique Opportunity for Experts in Device and Drug Therapies to Share Knowledge Indianapolis, IN - A major international heart failure symposium co-sponsored by...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
New Trial Signifies Continued Leadership in Heart Failure Clinical Science Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Guidant's Institute for Therapy Advancement - Japan Continues Leadership in Medical Education Indianapolis, Ind. and Tokyo, Japan - Guidant Corporation (NYSE: GDT), a world leader in the treatment...
State-of-the-Art Simulation Programs Expand Guidant''s Medical Education Offerings to Physicians Indianapolis, Ind. and Brussels, Belgium - Guidant Corporation (NYSE: GDT), a world leader in the...
Meeting to be held in Indianapolis on May 19 Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...
New Indication Allows Physicians to Harvest Artery in Arm For Coronary Bypass Graft Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the...
Landmark Trials Featured Indianapolis, Ind. and St. Paul, Minn. - Two Guidant Corporation (NYSE: GDT) sponsored clinical trials will be prominently featured during the 24th annual meeting of the...